Re-evaluating the Role of Antibodies in Tuberculosis
by Pia Steigler, PhD
References
Alene, K. A., Wangdi, K., Colquhoun, S., Chani, K., Islam, T., Rahevar, K., Morishita, F., Byrne, A.,
Clark, J., & Viney, K. (2021). Tuberculosis related disability: a systematic review and meta-analysis.
BMC Medicine, 19(1). https://doi.org/10.1186/S12916-021-02063-9
Awoniyi, D. O., Baumann, R., Chegou, N. N., Kriel, B., Jacobs, R., Kidd, M., Loxton, A. G.,
Kaempfer, S., Singh, M., & Walzl, G. (2017). Detection of a combination of serum IgG and IgA
antibodies against selected mycobacterial targets provides promising diagnostic signatures for ac-
tive tuberculosis. Oncotarget, 8, 37525–37537. https://doi.org/10.18632/oncotarget.16401
Baumann, R., Kaempfer, S., Chegou, N. N., Oehlmann, W., Loxton, A. G., Kaufmann, S. H. E., van
Helden, P. D., Black, G. F., Singh, M., & Walzl, G. (2014). Serologic diagnosis of tuberculosis by
combining Ig classes against selected mycobacterial targets. The Journal of Infection, 69(6), 581–589.
https://doi.org/10.1016/J.JINF.2014.05.014
Bekker, L. G., Dintwe, O., Fiore-Gartland, A., Middelkoop, K., Hutter, J., Williams, A., Randhawa, A.
K., Ruhwald, M., Kromann, I., Andersen, P. L., DiazGranados, C. A., Rutkowski, K. T., Tait, D., Miner,
M. D., Andersen-Nissen, E., de Rosa, S. C., Seaton, K. E., Tomaras, G. D., McElrath, M. J., … Kublin,
J. G. (2020). A phase 1b randomized study of the safety and immunological responses to vaccination
with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents
in Cape Town, South Africa. EClinicalMedicine, 21. https://doi.org/10.1016/j.eclinm.2020.100313
Brown, S., Leavy, J. E., & Jancey, J. (2021). Implementation of GeneXpert for TB testing in low- and
middle-income countries: a systematic review. Global Health: Science and Practice, 9(3), 698–710.
https://doi.org/10.9745/GHSP-D-21-00121
Bulterys, M. A., Wagner, B., Regard-Jacot, M., Suresh, A., Pollock, N. R., Moreau, E., Denkinger, C.
M., Drain, P. K., & Broger, T. (2019). Point-of-care urine LAM tests for tuberculosis diagnosis: a status
update. Journal of Clinical Medicine 2020, Vol. 9, Page 111, 9(1), 111.
https://doi.org/10.3390/JCM9010111
Carrère-Kremer, S., Kolia-Diafouka, P., Pisoni, A., Bolloré, K., Peries, M., Godreuil, S., Bourdin, A.,
van de Perre, P., & Tuaillon, E. (2022). QuantiFERON-TB Gold Plus assay in patients with latent vs.
active tuberculosis in a low incidence setting: level of IFN-γ, CD4/CD8 responses, and release of IL-
2, IP-10, and MIG. Frontiers in Microbiology, 13. https://doi.org/10.3389/FMICB.2022.825021
Casadevall, A., & Scharff, M. D. (1995). Return to the past: the case for antibody-based therapies in
infec tious diseases. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society
of America, 21(1), 150–161. https://doi.org/doi: 10.1093/clinids/21.1.150
Chen, T., Blanc, C., Eder, A. Z., Prados-Rosales, R., Souza, A. C. O., Kim, R. S., Glatman-Freedman,
A., Joe, M., Bai, Y., Lowary, T. L., Tanner, R., Brennan, M. J., Fletcher, H. A., McShane, H., Casade-
vall, A., & Achkar, J. M. (2016). Association of human antibodies to arabinomannan with en-
hanced mycobacterial opsonophagocytosis and intracellular growth reduction. Journal of Infectious
Diseases, 214(2), 300–310. https://doi.org/10.1093/infdis/jiw141
Desikan, P., Tiwari, K., Panwalkar, N., Khaliq, S., Chourey, M., Varathe, R., Mirza, S. B., Sharma, A.,
Anand, S., & Pandey, M. (2017). Public health relevance of non-tuberculous mycobacteria among
AFB posi tive sputa. Germs, 7(1), 10. https://doi.org/10.18683/GERMS.2017.1103